RETRACTED ARTICLE: Synthesis and biological evaluation of entecavir 4′-ester derivatives

Deri Feng , Jiaan Liu , Shuang Liang , Yanyan Wang , Youjun Xu

Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (5) : 749 -754.

PDF
Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (5) : 749 -754. DOI: 10.1007/s40242-014-4183-y
Article

RETRACTED ARTICLE: Synthesis and biological evaluation of entecavir 4′-ester derivatives

Author information +
History +
PDF

Abstract

Entecavir can significantly inhibit the replication of HBV-DNA, reduce the HBV-DNA level in blood serum. But suffering from low oral bioavailability, entecavir has low intestinal membrane permeability and poor metabolic stability. In this study, 12 different derivatives of entecavir 4′-ester were regioselectively synthesized and their apical-to-basolateral permeabilities across Caco-2 cells and HBV-DNA inhibitory efficacies were evaluated. Most of the compounds showed high permeabilities across Caco-2 cells compared with entecavir, compounds 5b and 5e also exhibited comparable anti-HBV activities with that of entecavir, especially.

Keywords

Entecavir / Anti-HBV activity / Intestinal membrane permeability

Cite this article

Download citation ▾
Deri Feng, Jiaan Liu, Shuang Liang, Yanyan Wang, Youjun Xu. RETRACTED ARTICLE: Synthesis and biological evaluation of entecavir 4′-ester derivatives. Chemical Research in Chinese Universities, 2014, 30(5): 749-754 DOI:10.1007/s40242-014-4183-y

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Shi C C, Tjwa E T, Biesta P J, Boonstra A, Xie Q, Janssen H L, Woltman A M. J. Vir. Hepatitis, 2012, 19(2): 26.

[2]

Pothakamuri V S, Sven P, Verena S, Jan G, Paraskevi F, Anna G, Birgit BB, Antoaneta M, Jerzy J, Christoph B, Michael P M, Markus C, Heiner W. Hepatology, 2012, 55(3): 695.

[3]

Jensbukh M D, Robert E, Lanford P D, Robert H, Purcell M D. Hepatology, 2013, 58(5): 1533.

[4]

Rehermann B, Nascimbeni M. Nat. Rev. Immunol., 2005, 5(3): 215.

[5]

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini C, Orlandini A, Sacchelli L, Missale G, Ferrari C. Hepatology, 2009, 58: 974.

[6]

Daniel G, Maximilian H, Robert T. Clin. Sci., 2013, 124: 77.

[7]

Han Q J, Zhang C, Zhang J, Tian Z G. Semin. Immunopathol, 2013, 35(1): 23.

[8]

Dienstag J L, Perrillo R P, Schiff E R, Bartholomew M, Vicary C, Rubin M. N. Engl. J. Med., 1995, 333: 1657.

[9]

Cullen J M, Li D H, Brown C, Eisenberg E J, Cundy K C, Wolfe J, Toole J, Gibbs C. Antimicrob. Agents Chemother., 2001, 45(10): 2740.

[10]

Stevens R C, Blum M R, Rousseau F S, Kearney B P, Anderson P L, Kakuda T N, Lichtenstein K A. Clin. Infect. Dis., 2004, 39: 877.

[11]

Marcellin P, Mommeja M H, Sacks S L, Lau G K, Sereni D, Bronowicki J P, Conway B, Trepo C, Blum M R, Yoo B C, Mondou E, Sorbel J, Snow A, Rousseau F, Lee H S. Hepatology, 2004, 40: 140.

[12]

Chu C K, Ma L, Olgen S, Pierra C, Du J, Gumina G, Gullen E, Cheng Y C, Schinazi R F. J. Med. Chem., 2000, 43(21): 3906.

[13]

Honkoop P, Deman R A. Opin. Investig. Drugs, 2003, 12(4): 683.

[14]

Tenney D J, Levine S M, Rose R E, Walsh A W, Weinheimer S P, Discotto L, Plym M, Pokornowski K, Yu C F, Angus P, Ayres A, Bartholomeusz A, Sievert W, Thompson G, Warner N, Locarnini S, Colonno R J. Antimicrob. Agents Chemother., 2004, 48(9): 3498.

[15]

Innaimo S F, Seifer M, Bisacchi G S, Standring D N, Zahler R, Colonno R J. Antimicrob. Agents. Chemoter., 1997, 41: 1444.

[16]

Buti M, Esteban R. J. Hepatol., 2003, 39(2): 239.

[17]

Benjahad A, CouRte K, Guillemont J, Mabire D, Coupa S, Poncelet A, Csoka I, Andries K, Pauwels R, de Bethune M P, Monneret C, Bisagni E, Nguyen C H, Grierson D S. J. Med. Chem., 2004, 47(22): 5501.

[18]

Lv Z, Sheng C, Wang T. J. Med. Chem., 2010, 53(18): 6600.

[19]

Sun Y B, Sun J, Shi S L, Jing Y K, Yin S L, Chen Y, Li G, Xu Y J, He Z G. Mol. Pharmaceutics, 2009, 6(1): 315.

[20]

Yan Z T, Sun J, Chang Y N, Liu Y H, Fu Q, Xu Y J, Sun Y B, Pu X H, Zhang Y X, Jing Y K, Yin S L, Zhu M, Wang Y J, He Z G. Mol. Pharmaceutics, 2011, 8(2): 319.

[21]

Balimane P V, Tamai I, Guo A L, Nakanishi T, Kitada H, Leibach F H, Tsuji A, Sinko P J. Biochem. Biophys. Res. Commun., 1998, 250: 246.

[22]

Bueno A B, Collado I, de Dios A, Domingguez C, Martin J A, Martin L M, Matinez-Grau M A, Montero C, Pedregal C, Catlow J, Coffey D S, Cley MP, Dantzig A H, Lindstrom T, Monn J A, Jiang H Y, Schoepp D D, Stratford R E, Tabas L B, Tizaano J P, Wright R A, Herin M F. J. Med. Chem., 2005, 48(16): 5305.

[23]

Zhang Y X, Sun J, Gao Y K, Jin L, Xu Y J, Lian H, Sun Y B, Sun Y H, Liu J Y, Fan R, Zhang T H, He Z G. Mol. Pharmaceutics, 2013, 10(8): 3195.

[24]

Perkins E J, Abraham T. Drug Metab. Dispos., 2007, 35(10): 1903.

[25]

Gregory Y, Todd W, Steven I, Gregory S B, Peter E, Kent R, Robert Z, Richard J C. Antimicrob. Agents Chemother., 1999, 43(1): 190.

[26]

Liu Y, Lu B W, Lu J R, Xin C W, Li J F, Mu J B, Bao X R. Chem. Res. Chinese Universities, 2013, 29(3): 449.

AI Summary AI Mindmap
PDF

140

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/